Jay Harvey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jay Harvey has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- Kan Ding
Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8508, USA
6 shared publications - Ghazala Perven
Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
4 shared publications Hailong Cheng
Sunovion Pharmaceuticals Inc., Marlborough, MA, USA
4 shared publications- Hina Dave
Ochsner Medical Center, New Orleans, LA, USA
4 shared publications - Irina Podkorytova
Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
4 shared publications - Mehrdad Nourani
Department of Electrical and Computer Engineering, The University of Texas at Dallas, Richardson, TX, USA
4 shared publications
Latest Publications
- 28 April 2026
- Published by World Scientific Pub Co Pte Ltd in International Journal of Neural Systems
- Vol. 36 (11) , 2650037
Frequency Band Personalization for Seizure Network Analysis in Multifocal Patients
Stereo-electroencephalography (SEEG) is commonly used for pre-surgical evaluation in patients with multifocal epilepsy undergoing responsive neurostimulation (RNS). Seizure network modeling, a data-driven approach to assist RNS implantation and adjustment, benefits from individualized ictal signatures learned from SEEG data, including repetitive sharp waves, rhythmic discharges, and prominent frequency bands in seizure activities. This is all in pursuit of the earliest possible detection so that the RNS therapy can be delivered as soon as a potential seizure is on the horizon. To improve individualized treatment, this paper proposes a data-driven methodology for personalizing frequency-band selection using a SEEG-based seizure network in patients with multifocal epilepsy. A directed seizure network is first proposed using SEEG data, where network nodes are selected SEEG points, and spectral edges are characterized by a directed transfer function. To further enhance the robustness of network modeling, surrogate data analysis is applied to ensure the significance of network estimation. Then, the density differences between the seizure onset zone and remaining regions are extracted using subgraph density as a heuristic to select the discriminative frequency range with the highest difference as the optimal band. The selection result is further validated using a machine learning classifier for seizure detection. Across ten multifocal patients, our personalized selection achieved an Area-Under score of 0.94 out of 1 in the seizure classification task, outperforming standard bands in distinguishing ictal from pre-ictal states, and exhibiting type-specific spectral patterns with consistency through different frequency-domain network metrics.
- 28 April 2026
- Published by World Scientific Pub Co Pte Ltd in International Journal of Neural Systems
- Vol. 36 (11) , 2650037
Frequency Band Personalization for Seizure Network Analysis in Multifocal Patients
Stereo-electroencephalography (SEEG) is commonly used for pre-surgical evaluation in patients with multifocal epilepsy undergoing responsive neurostimulation (RNS). Seizure network modeling, a data-driven approach to assist RNS implantation and adjustment, benefits from individualized ictal signatures learned from SEEG data, including repetitive sharp waves, rhythmic discharges, and prominent frequency bands in seizure activities. This is all in pursuit of the earliest possible detection so that the RNS therapy can be delivered as soon as a potential seizure is on the horizon. To improve individualized treatment, this paper proposes a data-driven methodology for personalizing frequency-band selection using a SEEG-based seizure network in patients with multifocal epilepsy. A directed seizure network is first proposed using SEEG data, where network nodes are selected SEEG points, and spectral edges are characterized by a directed transfer function. To further enhance the robustness of network modeling, surrogate data analysis is applied to ensure the significance of network estimation. Then, the density differences between the seizure onset zone and remaining regions are extracted using subgraph density as a heuristic to select the discriminative frequency range with the highest difference as the optimal band. The selection result is further validated using a machine learning classifier for seizure detection. Across ten multifocal patients, our personalized selection achieved an Area-Under score of 0.94 out of 1 in the seizure classification task, outperforming standard bands in distinguishing ictal from pre-ictal states, and exhibiting type-specific spectral patterns with consistency through different frequency-domain network metrics.
- Open Access
- 24 January 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 33 (15344320) , 664-674
SEEG-Based Bilateral Seizure Network Analysis for Neurostimulation Treatment
Objective: Epilepsy patients with drug-resistant seizures emanating from two or more distinct regions of left and right hemispheres are the primary candidates for neurostimulation treatment. Stereo-electroencephalography (SEEG) is a minimally invasive technique to monitor and evaluate brain activities during seizures before stimulator implantation. Methods: This work proposes a seizure network modeling method using SEEG to analyze the functional connectivity of epileptogenic zone during bilateral seizures. Network nodes are selected subset of SEEG contact points, and network edges are directed signal correlations calculated from directed transfer function. Based on signal directionality, four connectivity values are extracted to measure the intra- and inter-activities that are within or between the left and right hemispheres, respectively. Statistical difference between connectivity values is used to quantify the seizure impact of each hemisphere. A subset of network nodes is selected from impactful side as stimulation target candidates. Results: Experimental results are validated on ten patients having different seizure types with bilateral onset. Each seizure type has specific connectivity patterns that show different importance from each brain side. Selection of neurostimulation targets from primary side are consistent with clinicians’ decision. Relationships are found among connectivity differences, seizure types and stimulation outcomes. Conclusion: Using SEEG signals, we can capture specific connectivity differences associated with bilateral seizure networks. Such differences are related with corresponding neurostimulation targets and stimulating outcomes. Significance: The proposed work elucidates the difference of network connectivity for bilateral patients, and assists clinicians to choose the stimulation targets and to predict the potential outcomes.
- 24 January 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. 33 (15344320) , 664-674
Open AccessSEEG-Based Bilateral Seizure Network Analysis for Neurostimulation Treatment
Objective: Epilepsy patients with drug-resistant seizures emanating from two or more distinct regions of left and right hemispheres are the primary candidates for neurostimulation treatment. Stereo-electroencephalography (SEEG) is a minimally invasive technique to monitor and evaluate brain activities during seizures before stimulator implantation. Methods: This work proposes a seizure network modeling method using SEEG to analyze the functional connectivity of epileptogenic zone during bilateral seizures. Network nodes are selected subset of SEEG contact points, and network edges are directed signal correlations calculated from directed transfer function. Based on signal directionality, four connectivity values are extracted to measure the intra- and inter-activities that are within or between the left and right hemispheres, respectively. Statistical difference between connectivity values is used to quantify the seizure impact of each hemisphere. A subset of network nodes is selected from impactful side as stimulation target candidates. Results: Experimental results are validated on ten patients having different seizure types with bilateral onset. Each seizure type has specific connectivity patterns that show different importance from each brain side. Selection of neurostimulation targets from primary side are consistent with clinicians’ decision. Relationships are found among connectivity differences, seizure types and stimulation outcomes. Conclusion: Using SEEG signals, we can capture specific connectivity differences associated with bilateral seizure networks. Such differences are related with corresponding neurostimulation targets and stimulating outcomes. Significance: The proposed work elucidates the difference of network connectivity for bilateral patients, and assists clinicians to choose the stimulation targets and to predict the potential outcomes.
- Open Access
- 9 January 2025
- Published by Association for Computing Machinery (ACM) in ACM Transactions on Computing for Healthcare
- Vol. 6 (1) , 1-31
An Unobtrusive and Lightweight Ear-worn System for Continuous Epileptic Seizure Detection
Epilepsy is one of the most common neurological diseases globally (around 50M people globally). Fortunately, up to 70% of people with epilepsy could live seizure-free if properly diagnosed and treated, and a reliable technique to monitor the onset of seizures could improve the quality of life of patients who are constantly facing the fear of random seizure attacks. The current gold standard, video-EEG (v-EEG), involves attaching over 20 electrodes to the scalp, is costly, requires hospitalization, trained professionals, and is uncomfortable for patients. To address this gap, we developed EarSD , a lightweight and unobtrusive ear-worn system to detect seizure onsets by measuring physiological signals behind the ears. This system can be integrated into earphones, headphones, or hearing aids, providing a convenient solution for continuous monitoring. EarSD is an integrated custom-built sensing - computing - communication ear-worn platform to capture seizure signals, remove the noises caused by motion artifacts and environmental impacts, and stream the collected data wirelessly to the computer/mobile phone nearby. EarSD ’s ML algorithm, running on a server, identifies seizure-associated signatures and detects onset events. We evaluated the proposed system in both in-lab and in-hospital experiments at the University of Texas Southwestern Medical Center with epileptic seizure patients, confirming its usability and practicality.
- 9 January 2025
- Published by Association for Computing Machinery (ACM) in ACM Transactions on Computing for Healthcare
- Vol. 6 (1) , 1-31
Open AccessAn Unobtrusive and Lightweight Ear-worn System for Continuous Epileptic Seizure Detection
Epilepsy is one of the most common neurological diseases globally (around 50M people globally). Fortunately, up to 70% of people with epilepsy could live seizure-free if properly diagnosed and treated, and a reliable technique to monitor the onset of seizures could improve the quality of life of patients who are constantly facing the fear of random seizure attacks. The current gold standard, video-EEG (v-EEG), involves attaching over 20 electrodes to the scalp, is costly, requires hospitalization, trained professionals, and is uncomfortable for patients. To address this gap, we developed EarSD , a lightweight and unobtrusive ear-worn system to detect seizure onsets by measuring physiological signals behind the ears. This system can be integrated into earphones, headphones, or hearing aids, providing a convenient solution for continuous monitoring. EarSD is an integrated custom-built sensing - computing - communication ear-worn platform to capture seizure signals, remove the noises caused by motion artifacts and environmental impacts, and stream the collected data wirelessly to the computer/mobile phone nearby. EarSD ’s ML algorithm, running on a server, identifies seizure-associated signatures and detects onset events. We evaluated the proposed system in both in-lab and in-hospital experiments at the University of Texas Southwestern Medical Center with epileptic seizure patients, confirming its usability and practicality.
- Open Access
- 28 February 2024
- Published by Elsevier in Clinical Neurophysiology Practice
- Vol. 9, 106-111
Stereo-electroencephalographic seizure localization in patients with mesial temporal sclerosis: A single center experience
- 28 February 2024
- Published by Elsevier in Clinical Neurophysiology Practice
- Vol. 9, 106-111
Open AccessStereo-electroencephalographic seizure localization in patients with mesial temporal sclerosis: A single center experience
- 8 November 2023
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 167, 107692
SEEG-based epileptic seizure network modeling and analysis for pre-surgery evaluation
- 8 November 2023
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 167, 107692
SEEG-based epileptic seizure network modeling and analysis for pre-surgery evaluation
- Open Access
- 8 October 2023
- Published by Association for Computing Machinery (ACM)
- p. 339-341
Earables as Medical Devices: Opportunities and Challenges
- 8 October 2023
- Published by Association for Computing Machinery (ACM)
- p. 339-341
Open AccessEarables as Medical Devices: Opportunities and Challenges
- 25 April 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 100 (17_supplem)
Provider and Patient Opinions on Real-Time Seizure Detection via Over-the-Ear Device (P10-1.005)
Objective: To examine epileptologist opinions and patient experiences regarding an over-the-ear real-time seizure detection device. Background: Our team developed BrainSD, a behind-the-ear seizure monitor that detects EEGs with four scalp contacts. BrainSD maximizes detection accuracy and usability for clinicians, and comfort and ease-of-use for patients. It was tested on 33 patients admitted to the Epilepsy Monitoring Unit (EMU) at a Level 4 Epilepsy Center. BrainSD was worn for 42 hours on average and recorded 14 seizure events. Design/Methods: An anonymous 14-question survey was offered to study participants at the end of the study. Subsequently, nine epileptologists were invited to a one-hour focus group to obtain opinions regarding portable seizure detection devices. Results: Thirty (91%) of thirty-three participants who wore BrainSD completed the post-survey. Of the thirty, seven (23.3%) strongly agreed and fifteen (50%) agreed that BrainSD was comfortable. Discomfort was expressed (16.7%) due to pressure, and the adhesive glue. Twelve (40%) strongly agreed and fourteen (46.7%) agreed that BrainSD was easy to use. Twelve (40%) patients said they would wear BrainSD continuously for over a week. Eight (26.7%) strongly agreed and ten (33.3%) agreed that BrainSD is socially acceptable to wear in public. Nine (30%) strongly agreed and ten (33.3%) agreed that they slept well while wearing BrainSD. For potential BrainSD improvements, three (10%) inquired about an auxiliary mobile application and six (20%) about seizure prediction and alerting. Providers expressed interest in a device that detects non-motor focal seizures; uploads recordings in real-time for viewing; alerts patients before an epileptic event; and allows patients to log their events. Hesitancies with over-the-ear devices included the risk of false positive rates with the implemented 2-channel EEG. Conclusions: BrainSD has the features that users desire, is acceptable and comfortable for patients, and meets epileptologists’ expectations. More features will be considered to optimize BrainSD in the future. Disclosure: Miss Venkatesh has nothing to disclose. Mr. Yao has nothing to disclose. Ms. Lehnen has nothing to disclose. The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS. Dr. Nguyen has nothing to disclose. Dr. Harvey has received personal compensation for serving as an employee of RSC Diagnostics. The institution of Dr. Harvey has received research support from GW Pharmaceuticals. The institution of Dr. Harvey has received research support from Cerevel Pharmaceuticals. The institution of Dr. Harvey has received research support from UCB Pharmaceuticals.
- 25 April 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 100 (17_supplem)
Provider and Patient Opinions on Real-Time Seizure Detection via Over-the-Ear Device (P10-1.005)
Objective: To examine epileptologist opinions and patient experiences regarding an over-the-ear real-time seizure detection device. Background: Our team developed BrainSD, a behind-the-ear seizure monitor that detects EEGs with four scalp contacts. BrainSD maximizes detection accuracy and usability for clinicians, and comfort and ease-of-use for patients. It was tested on 33 patients admitted to the Epilepsy Monitoring Unit (EMU) at a Level 4 Epilepsy Center. BrainSD was worn for 42 hours on average and recorded 14 seizure events. Design/Methods: An anonymous 14-question survey was offered to study participants at the end of the study. Subsequently, nine epileptologists were invited to a one-hour focus group to obtain opinions regarding portable seizure detection devices. Results: Thirty (91%) of thirty-three participants who wore BrainSD completed the post-survey. Of the thirty, seven (23.3%) strongly agreed and fifteen (50%) agreed that BrainSD was comfortable. Discomfort was expressed (16.7%) due to pressure, and the adhesive glue. Twelve (40%) strongly agreed and fourteen (46.7%) agreed that BrainSD was easy to use. Twelve (40%) patients said they would wear BrainSD continuously for over a week. Eight (26.7%) strongly agreed and ten (33.3%) agreed that BrainSD is socially acceptable to wear in public. Nine (30%) strongly agreed and ten (33.3%) agreed that they slept well while wearing BrainSD. For potential BrainSD improvements, three (10%) inquired about an auxiliary mobile application and six (20%) about seizure prediction and alerting. Providers expressed interest in a device that detects non-motor focal seizures; uploads recordings in real-time for viewing; alerts patients before an epileptic event; and allows patients to log their events. Hesitancies with over-the-ear devices included the risk of false positive rates with the implemented 2-channel EEG. Conclusions: BrainSD has the features that users desire, is acceptable and comfortable for patients, and meets epileptologists’ expectations. More features will be considered to optimize BrainSD in the future. Disclosure: Miss Venkatesh has nothing to disclose. Mr. Yao has nothing to disclose. Ms. Lehnen has nothing to disclose. The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS. Dr. Nguyen has nothing to disclose. Dr. Harvey has received personal compensation for serving as an employee of RSC Diagnostics. The institution of Dr. Harvey has received research support from GW Pharmaceuticals. The institution of Dr. Harvey has received research support from Cerevel Pharmaceuticals. The institution of Dr. Harvey has received research support from UCB Pharmaceuticals.
- 1 September 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 122, 108225
Emergency department visits and readmissions in patients with psychogenic nonepileptic seizures (PNES) at a safety net hospital
- 1 September 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 122, 108225
Emergency department visits and readmissions in patients with psychogenic nonepileptic seizures (PNES) at a safety net hospital
- 3 April 2021
- Published by Taylor & Francis in The Neurodiagnostic Journal
- Vol. 61 (2) , 95-103
Emergent Admissions to the Epilepsy Monitoring Unit in the Setting of COVID-19 Pandemic-related, State-mandated Restrictions: Clinical Decision Making and Outcomes
Due to the coronavirus disease 2019 (COVID-19) pandemic, the state of Texas-limited elective procedures to conserve beds and personal protective equipment (PPE); therefore, between March 22 and May 18, 2020, admission to the epilepsy monitoring unit (EMU) was limited only to urgent and emergent cases. We evaluated clinical characteristics and outcomes of these patients who were admitted to the EMU. Nineteen patients were admitted (one patient twice) with average age of 36.26 years (11 female) and average length of stay 3 days (range: 2–9 days). At least one event was captured on continuous EEG (cEEG) and video monitoring in all 20 admissions (atypical in one). One patient had both epileptic (ES) and psychogenic non-epileptic seizures (PNES) while 10 had PNES and 9 had ES. In 8 of 9 patients with ES, medications were changed, while in 5 patients with PNES, anti-epileptic drugs (AED) were stopped; the remaining 5 were not on medications. Of the 14 patients who had seen an epileptologist pre-admission, 13 (or 93%) had their diagnosis confirmed by EMU stay; a statistically significant finding. While typically an elective admission, in the setting of the COVID-19 pandemic, urgent and emergent EMU admissions were required for increased seizure or event frequency. In the vast majority of patients (13 of 19), admission lead to medication changes to either better control seizures or to change therapeutics as appropriate when PNES was identified.
- 3 April 2021
- Published by Taylor & Francis in The Neurodiagnostic Journal
- Vol. 61 (2) , 95-103
Emergent Admissions to the Epilepsy Monitoring Unit in the Setting of COVID-19 Pandemic-related, State-mandated Restrictions: Clinical Decision Making and Outcomes
Due to the coronavirus disease 2019 (COVID-19) pandemic, the state of Texas-limited elective procedures to conserve beds and personal protective equipment (PPE); therefore, between March 22 and May 18, 2020, admission to the epilepsy monitoring unit (EMU) was limited only to urgent and emergent cases. We evaluated clinical characteristics and outcomes of these patients who were admitted to the EMU. Nineteen patients were admitted (one patient twice) with average age of 36.26 years (11 female) and average length of stay 3 days (range: 2–9 days). At least one event was captured on continuous EEG (cEEG) and video monitoring in all 20 admissions (atypical in one). One patient had both epileptic (ES) and psychogenic non-epileptic seizures (PNES) while 10 had PNES and 9 had ES. In 8 of 9 patients with ES, medications were changed, while in 5 patients with PNES, anti-epileptic drugs (AED) were stopped; the remaining 5 were not on medications. Of the 14 patients who had seen an epileptologist pre-admission, 13 (or 93%) had their diagnosis confirmed by EMU stay; a statistically significant finding. While typically an elective admission, in the setting of the COVID-19 pandemic, urgent and emergent EMU admissions were required for increased seizure or event frequency. In the vast majority of patients (13 of 19), admission lead to medication changes to either better control seizures or to change therapeutics as appropriate when PNES was identified.
- Open Access
- 1 January 2021
- Published by Elsevier in Epilepsy & Behavior Reports
- Vol. 15, 100441
Non-lesional mesial temporal lobe epilepsy requires bilateral invasive evaluation
- 1 January 2021
- Published by Elsevier in Epilepsy & Behavior Reports
- Vol. 15, 100441
Open AccessNon-lesional mesial temporal lobe epilepsy requires bilateral invasive evaluation